Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering Plough Rebetol pediatric approval

Executive Summary

Schering Plough's Rebetol (ribavirin) capsules and oral solution approved July 30 for treatment of pediatric hepatitis C. Rebetol is indicated for use in combination with Schering's Intron A (interferon) "for the treatment of chronic hepatitis C in patients 3 years of age and older with compensated liver disease previously untreated with alpha interferon," Schering says. Company has plans for Rebetol pediatric study in combination with PEG-Intron. FDA grants orphan drug status to pediatric use...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS042255

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel